Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome

Fig. 2

Survival curves of the 72 patients with unresectable LASCC. A Overall survival (OS), B progression-free survival (PFS), C locoregional recurrence‑free survival (RFS), D metastasis‑free survival(MFS)survival curves of the 72 patients with unresectable LASCC. The estimated 3-year OS, PFS, RFS and MFS were 75.8%, 70.7%, 89.0%, and 75.2%, respectively

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us